(Press-News.org) COLUMBUS, Ohio - Chest pain is a scary symptom that sends more than 7 million Americans to the emergency department each year. About half of them are admitted to the hospital for further observation, testing or treatment. Now, emergency medicine physicians at The Ohio State University Wexner Medical Center and Mount Carmel Health System believe that number can be significantly reduced.
Their study, published in today's JAMA Internal Medicine, finds a very low short-term risk for life-threatening cardiac events among patients with chest pain who have normal cardiac blood tests, vital signs and electrocardiograms.
"We wanted to determine the risk to help assess whether this population of patients could safely go home and do further outpatient testing within a day or two," said Dr. Michael Weinstock, a professor of Emergency Medicine at The Ohio State University College of Medicine and chairman of the Emergency Department at Mt. Carmel St. Ann's Hospital.
The researchers looked at data from 45,416 emergency department visits for chest pain at three Columbus-area hospitals between July 2008 and June 2013. Of those, 11,230 met the criteria for the study. Weinstock and colleagues looked for a primary outcome of life-threatening arrhythmia, inpatient heart attack, cardiac or respiratory arrest, or death. One of these bad outcomes occurred in four of the patients. Using a random sample of the medical records, that translates to a life-threatening event in 0.06 percent of these patients, or one in every 1,817.
"This data shows routine hospital admission is not the best strategy for this group. We tend to admit a lot of people with chest pain out of concern for missing a heart attack or some other life-ending irregularity," Weinstock said. "To me, this says we can think more about what's best for the patient long term. I've been having these conversations with my patients, and only one wanted to stay in the hospital. Most people want to go home and get tests done the next day."
Additionally, Weinstock and his team believe current national guidelines to routinely admit, observe and test patients after a clean emergency department evaluation for chest pain should be reconsidered.
"We'd like to see more emergency medicine physicians having that bedside conversation to ensure the chest pain patient knows the risks and benefits of hospitalization compared to outpatient evaluation. We think continuing evaluation in an outpatient setting is not only safer for the patient, it's a less costly approach for the health care system," Weinstock said.
INFORMATION:
Additional team members included Dr. Colin Kaide from The Ohio State University Wexner Medical Center, Dr. Frank Orth, Dr. Douglas VanFossen and Judy Anderson from Mt. Carmel St. Ann's, Dr. Scott Weingart from Stony Brook Medicine and Dr. David Newman from Icahn School of Medicine.
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads. The work was funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health.
Circulating tumor cells (CTCs) are cells that break away from a tumor and move through a cancer patient's bloodstream. Single CTCs are extremely rare, typically fewer than 1 in 1 billion cells. These cells can take up residence in distant organs, and researchers ...
TEMPE, Arizona -- Electricity generation and distribution infrastructure in the Western United States must be "climate-proofed" to diminish the risk of future power shortages, according to research by two Arizona State University engineers.
Expected increases in extreme heat and drought events will bring changes in precipitation, air and water temperatures, air density and humidity, write Matthew Bartos and Mikhail Chester in the current issue of the research journal Nature Climate Change.
The authors say the changing conditions could significantly constrain the energy ...
Suicide is a leading cause of death among children younger than 12 years. Suicide rates in this age group have remained steady overall for the past 20 years, but a study published today in JAMA Pediatrics from The Research Institute at Nationwide Children's Hospital is the first national study to observe higher suicide rates among black children compared to white children.
"Little is known about the epidemiology of suicide in this age group," said Jeff Bridge, PhD, lead researcher of the study and principal investigator at the Center for Innovation in Pediatric Practice ...
A team led by UCSF researchers has discovered how a commonly administered vaccine protects against acute lymphoblastic leukemia (ALL), the most common type of childhood cancer.
The Haemophilus influenzae Type b (Hib) vaccine not only prevents ear infections and meningitis caused by the Hib bacterium, but also protects against ALL, which accounts for approximately 25 percent of cancer diagnoses among children younger than 15 years, according to the National Cancer Society. The Hib vaccine is part of the standard vaccination schedule recommended by the Centers for Disease ...
WINSTON-SALEM, N.C. - May 18, 2015 - New proof-of-concept research at Wake Forest Institute for Regenerative Medicine suggests the potential for engineering replacement intestine tissue in the lab, a treatment that could be applied to infants born with a short bowel and adults having large pieces of gut removed due to cancer or inflammatory bowel disease.
Lead researcher Khalil N Bitar, Ph.D., a professor at the institute, which is part of Wake Forest Baptist Medical Center, reported the results this week at Digestive Diseases Week in Washington, D.C. He also updated ...
The MET-proto-oncogene is involved in the pathogenesis of several tumors and therefore represents an interesting target for future therapies currently tested in dozens of clinical trials. Veronica Finisguerra, Andrea Casazza, Max Mazzone and colleagues from VIB, KU Leuven and UZ Leuven now reveal that MET is needed for the recruitment of anti-tumoral neutrophils and puts a mechanism into action that promotes the killing of cancer cells. This means that the efficacy of a cancer therapy targeting MET in cancer cells will partly be countered by the pro-tumoral effect arising ...
Moonshiners and home-brewers have long used yeast to convert sugar into alcohol. New research shows that those methods could also be adapted for something with more significant ramifications: the production of drugs including opiates, antibiotics, and anti-cancer therapeutics.
According to new studies by researchers from Concordia University in Montreal and the University of California, Berkeley, yeast can be engineered to convert sugar to alkaloids -- plant-derived compounds such as codeine and morphine, naturally produced in the opium poppy.
Collaborating on synthesis ...
Long range weather forecasts and climate change projections could be significantly boosted by advances in our understanding of the relationship between layers of the Earth's atmosphere -- the stratosphere and troposphere.
A team of UK scientists have studied how a circulation changes in the stratosphere (above 10 km) can influence both weather and climate conditions on the surface of the Earth.
The experts, who include Professor Mark Baldwin from the University of Exeter, argue that the predictability and persistence of stratospheric events could help scientists enhance ...
In what they are calling a surprising finding in a large study of men who completed questionnaires and allowed scientists to review their medical records, Johns Hopkins researchers report that men with a history of asthma were less likely than those without it to develop lethal prostate cancer.
In their analysis of data collected from 47,880 men and described online Feb. 27 in the International Journal of Cancer, the scientists found that men with a history of asthma were 29 percent less likely to have been diagnosed with prostate cancer that spread or to have died of ...
CAMBRIDGE, MA -- Biomedical devices that can be implanted in the body for drug delivery, tissue engineering, or sensing can help improve treatment for many diseases. However, such devices are often susceptible to attack by the immune system, which can render them useless.
A team of MIT researchers has come up with a way to reduce that immune-system rejection. In a study appearing in the May 18 issue of Nature Materials, they found that the geometry of implantable devices has a significant impact on how well the body will tolerate them.
Although the researchers expected ...
